documents: FDA-2000-P-0102-0011
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2000-P-0102-0011 | FDA | FDA-2000-P-0102 | Tab 1 - CFSAN, FDA-Letter of Enforcement Discretion from FDA to Cargill Health & Food Technologies. Docket No. FDA-2000-P-0102, Document ID DRAFT-0059 (Formerly 2000P-1275/LET3) & Docket No. FDA-2000-P-0133, Document ID DRAFT-0127 (Formerly 2000P-1276/LET4). February 14, 2003 - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] - Background Material | Supporting & Related Material | BKG- Background Material (internal references) | 2010-12-13T05:00:00Z | 2010 | 12 | 2010-12-14T02:28:46Z | 0 | 0 | 0900006480bad901 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref